サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1678795

ストーマケア用品の世界市場（2025年～2033年）

Global Ostomy Care Devices Market - 2025-2033

出版日
ページ情報
英文 220 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
ストーマケア用品の世界市場（2025年～2033年）
出版日: 2025年03月11日
発行: DataM Intelligence
ページ情報: 英文 220 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のストーマケア用品の市場規模は、2024年に35億4,000万米ドルに達し、2033年には75億1,000万米ドルに達すると予測され、予測期間2025年～2033年にはCAGR7.8%で成長すると予測されています。

ストーマケア用品は、人工肛門、イレオストミー、ウロストミーなどのストーマ手術を受けた人の排泄物管理や患者の快適性を確保するために使用される医療製品です。技術、防臭、漏れ防止、肌に優しい材料の進歩は、患者の生活の質を向上させます。ストーマケア用品市場は、ストーマ手術を受けた患者をサポートするために設計された製品の生産、流通、販売を包含します。

オストミーは、消化器系または泌尿器系の一部を、ストーマとして知られる体外の開口部に外科的に迂回させることを含みます。この処置は、大腸がん、炎症性腸疾患（クローン病や潰瘍性大腸炎など）、膀胱がん、特定の先天性疾患などの疾患を抱える患者に対して一般的に行われます。

市場力学：

促進要因と抑制要因

炎症性腸疾患の有病率の上昇

クローン病や潰瘍性大腸炎などの炎症性腸疾患（IBD）の増加により、世界のストーマケア用品市場は活況を呈しています。これらの慢性疾患は外科的介入を必要とすることが多く、ストーマケア製品の需要増につながっています。特に先進諸国におけるIBDの発症率の増加は、食生活の変化、ストレス、遺伝的素因に起因しています。

例えば、2024年の調査では、潰瘍性大腸炎125万人、クローン病101万人を含む23億9,000万人のアメリカ大陸の人々がIBDに罹患していると推定されています。IBDの罹患率が最も高いのは北米で、米国では10万人年当たり721人が罹患しています。潰瘍性大腸炎の有病率はクローン病より高いですが、クローン病は10歳未満の小児に多くみられます。

239万人のアメリカ大陸の人々が罹患しているIBDの有病率の増加は、ストーマケア用品の需要を牽引しており、特にその割合が最も高い北米では、先進的なストーマ製品と付属品の大幅な市場成長をもたらしています。

高コストと限られた償還政策

ストーマケア用品の需要は増加していますが、高い製品コストと不十分な償還政策が市場の成長を妨げています。特に低・中所得国の患者は、先進的なストーマ製品を入手するための経済的障壁に直面しています。パウチや付属品の定期的なコストが患者の負担をさらに大きくし、採用率を低下させています。ヘルスケアシステムの償還方針は地域によって異なるため、さらに購入しやすさに影響を及ぼしています。これらの課題は、特に十分なサービスを受けていない市場において、ストーマケア用品の普及を妨げています。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 炎症性腸疾患の罹患率の上昇
      • 先進市場における有利な償還ポリシー
    • 抑制要因
      • 高額な費用と限定的な償還ポリシー
      • 厳格な規制要件
    • 機会
      • 新興市場への進出
    • 影響分析

第5章 戦略的洞察と業界展望

  • 市場のリーダーと先駆者
    • 新たな先駆者と著名な企業
    • 最大の売上を誇るブランドを確立したリーダー
    • 確立された製品を持つ市場リーダー
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の研究
  • 規制と償還の情勢
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • ポーターのファイブフォース分析
  • パイプライン分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格市場力学
  • キーオピニオンリーダー

第6章 製品タイプ別

  • ストーマバッグ
  • ワンピースシステム
  • ツーピースシステム
  • 付属品
  • ストーマパウダー
  • 接着剤とシーラント
  • ストーマペースト
  • その他

第7章 用途別

  • 人工肛門
  • イレオストミー
  • ウロストミー
  • その他

第8章 エンドユーザー別

  • 病院
  • 外来手術センター（ASC）
  • 在宅ケア環境

第9章 地域別

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • ラテンアメリカ
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • 中東・アフリカ

第10章 競合情勢

  • 競合シナリオ
  • 市況・シェア分析
  • M&A分析

第11章 企業プロファイル

  • Coloplast A/S
    • 会社概要
    • 製品ポートフォリオ
      • 製品説明
      • 製品の主要業績評価指標（KPI）
      • 実績および予測の製品販売
      • 製品販売量
    • 財務概要
      • 企業収益
      • 地域別収益分配
      • 収益予測
    • 主な発展
      • 合併と買収
      • 主な製品開発活動
      • 規制当局の承認等
    • SWOT分析
  • Hollister Incorporated
  • ConvaTec Group PLC
  • B. Braun Melsungen AG
  • 3M Company
  • Welland Medical Limited
  • Salts Healthcare Ltd
  • Torbot Group Inc
  • Byram Healthcare
  • Sarasota Medical Products
  • Marlen Manufacturing & Development Co
    • パイプライン製品の説明
    • 製品の主要業績評価指標（KPI）
    • 主な活動
    • 市場参入のタイムライン
    • 製品普及率
    • 売上推定と予測
  • Cymed Ostomy Co.
  • Schena Ostomy Technologies, Inc.
  • Alcare Co., Ltd.

第12章 付録

目次
Product Code: MD9290

The global ostomy care devices market reached US$ 3.54 billion in 2024 and is expected to reach US$ 7.51 billion by 2033, growing at a CAGR of 7.8% during the forecast period 2025-2033.

Ostomy care devices are medical products used to assist individuals with ostomy surgery, such as colostomy, ileostomy, or urostomy, managing waste and ensuring patient comfort. Advancements in technology, odor control, leak prevention, and skin-friendly materials enhance patient quality of life. The ostomy care devices market encompasses the production, distribution, and sale of products designed to support individuals who have undergone an ostomy procedure.

An ostomy involves surgically diverting part of the digestive or urinary system to an external opening on the body, known as a stoma. This procedure is commonly performed for patients dealing with conditions such as colorectal cancer, inflammatory bowel diseases (like Crohn's disease and ulcerative colitis), bladder cancer, and certain congenital disorders.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Inflammatory Bowel Diseases

The global ostomy care devices market is booming due to the rise in inflammatory bowel diseases (IBD), such as Crohn's and ulcerative colitis. These chronic conditions often require surgical interventions, leading to increased demand for ostomy care products. The growing incidence of IBD, particularly in developed countries, is attributed to changing dietary habits, stress, and genetic predispositions.

For instance, A 2024 study estimated that 2.39 Billion Americans have IBD, including 1.25 million with ulcerative colitis and 1.01 million with Crohn's disease. The highest rates of IBD are in North America, with 721 cases per 100,000 person-years in the US. The prevalence of ulcerative colitis is higher than Crohn's disease, but Crohn's disease is more prevalent among children under 10 years.

The increasing prevalence of IBD, affecting 2.39 million Americans, drives demand for ostomy care devices, particularly in North America, where the region has the highest rates, resulting in significant market growth for advanced ostomy products and accessories.

High Cost and Limited Reimbursement Policies

The demand for ostomy care devices is increasing, but high product costs and inadequate reimbursement policies hinder market growth. Patients, particularly in low- and middle-income countries, face financial barriers to access advanced ostomy products. Recurring costs of pouches and accessories further burden patients, reducing adoption rates. Healthcare systems' reimbursement policies vary across regions, further affecting affordability. These challenges hinder widespread accessibility of ostomy care devices, especially in underserved markets.

Segment Analysis

The global ostomy care devices market is segmented based on product type, application, end user and region.

Product Type:

Ostomy bags segment is expected to dominate the ostomy care devices with the highest market share

Ostomy bags are medical devices used to collect waste from the abdomen after a surgical procedure, particularly for individuals with gastrointestinal disorders like IBD or colorectal cancer. They come in one-piece and two-piece systems, with modern designs enhancing comfort and hygienic waste management, improving patient quality of life.

The ostomy bags segment is the top choice in the global ostomy care devices market due to their crucial role in waste management for individuals undergoing ostomy procedures. Unlike other accessories, ostomy bags are a primary necessity for patients, making them the most in-demand product category. They come in one-piece and two-piece systems, with one-piece systems being preferred for simplicity and ease of use, while two-piece systems offer flexibility and longer wear time.

Geographical Analysis

North America is expected to hold a significant position in the ostomy care devices market share

North America holds a substantial position in the ostomy care devices market and is expected to hold most of the market due to significant product launches, rising prevalence of IBD, colorectal cancer, and other gastrointestinal disorders. The region's healthcare infrastructure, key players, continuous product innovations, and favourable reimbursement policies drive market growth. The aging population fuels demand for high-quality ostomy bags and accessories.

For instance, in April 2024, Convatec launched Esteem Body with Leak Defense in the US, addressing the growing use of soft convexity ostomy barriers due to global obesity, which has nearly tripled since 1975. This trend has led to changes in abdominal topography and challenges in ostomy care management.

Hence, Convatec's launch of Esteem Body with Leak Defense in April 2024 enhances the ostomy care market by addressing the rising demand for soft convexity ostomy barriers, driven by increasing obesity rates. This innovation improves patient comfort and leak prevention, fostering market growth through higher adoption and advanced ostomy care solutions.

Competitive Landscape

The major global players in the ostomy care devices market include Coloplast A/S, Hollister Incorporated, ConvaTec Group PLC, B. Braun Melsungen AG, 3M Company, Welland Medical Limited, Salts Healthcare Ltd, Torbot Group Inc., Byram Healthcare and Sarasota Medical Products among others.

Key Developments

  • In July 2024, Revel, a leading ostomy care brand, introduced its first product, It's in the Bag, a deodorizing lubricant developed using LiquiGlide, an MIT-engineered technology. This product offers durable, self-lubricating, slippery surfaces and sets category-leading laboratory testing benchmarks, aiming to improve quality-of-life for ostomates.
  • In May 2024, Coloplast received reimbursement approval for the world's first digital leakage notification system, Heylo, and expanded its SenSura Mio ostomy range with two new products. The company's 2025 strategy, Strive25, aims to raise the standard of care for users and bring new products to market at a higher pace. Heylo detects potential leakages under the ostomy baseplate, notifying users at an early stage to prevent leakage progression.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing product launches and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Product Type & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

The global ostomy care devices market report delivers a detailed analysis with 61 key tables, more than 59 visually impactful figures, and 220 pages of expert insights, providing a complete view of the market landscape.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Prevalence of Inflammatory Bowel Diseases
      • 4.1.1.2. Favorable Reimbursement Policies in Developed Markets
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost and Limited Reimbursement Policies
      • 4.1.2.2. Stringent Regulatory Requirements
    • 4.1.3. Opportunity
      • 4.1.3.1. Expansion into Emerging Markets
    • 4.1.4. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with the largest selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa
  • 5.6. Porter's Five Force Analysis
  • 5.7. Pipeline Analysis
  • 5.8. Supply Chain Analysis
  • 5.9. Patent Analysis
  • 5.10. SWOT Analysis
  • 5.11. Unmet Needs and Gaps
  • 5.12. Recommended Strategies for Market Entry and Expansion
  • 5.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.14. Pricing Analysis and Price Dynamics
  • 5.15. Key Opinion Leaders

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Ostomy Bags*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. One-piece Systems
  • 6.4. Two-piece Systems
  • 6.5. Accessories
  • 6.6. Stoma Powder
  • 6.7. Adhesives and Sealants
  • 6.8. Stoma Paste
  • 6.9. Others

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Colostomy*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Ileostomy
  • 7.4. Urostomy
  • 7.5. Others

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Ambulatory Surgical Centers (ASCs)
  • 8.4. Home Care Settings

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Spain
      • 9.3.6.5. Italy
      • 9.3.6.6. Rest of Europe
  • 9.4. Latin America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Mexico
      • 9.4.6.2. Brazil
      • 9.4.6.3. Argentina
      • 9.4.6.4. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

Key Market Players

  • 11.1. Coloplast A/S*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals etc.
    • 11.1.5. SWOT Analysis
  • 11.2. Hollister Incorporated
  • 11.3. ConvaTec Group PLC
  • 11.4. B. Braun Melsungen AG
  • 11.5. 3M Company
  • 11.6. Welland Medical Limited
  • 11.7. Salts Healthcare Ltd
  • 11.8. Torbot Group Inc
  • 11.9. Byram Healthcare
  • 11.10. Sarasota Medical Products
  • Similar data will be provided for each market player.

Emerging Market Players

  • 11.11. Marlen Manufacturing & Development Co*
    • 11.11.1. Pipeline Products Description
    • 11.11.2. Product Key Performance Indicators (KPIs)
    • 11.11.3. Key Activities
    • 11.11.4. Market Entry Timelines
    • 11.11.5. Product Penetration Rate
    • 11.11.6. Sales Estimation and Projections
  • 11.12. Cymed Ostomy Co.
  • 11.13. Schena Ostomy Technologies, Inc.
  • 11.14. Alcare Co., Ltd.
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1 About Us and Services
  • 12.2 Contact Us